News

NEWS

LATEST NEWS

DLBCL is a rare, B-cell non-Hodgkin’s lymphoma that affects older adults.

Phase 1 Trial Outcomes With Urelumab in Relapsed or Refractory B-Cell Lymphoma

Micrograph of non-Hodgkin lymphoma

Clinical Response to Tisagenlecleucel Confers HRQoL Benefit in Lymphoma

Patterns of Cadiotoxicity Associated With Carfilzomib

Study Supports Less Frequent Dosing of Bortezomib in Multiple Myeloma

Computer illustration of chromosomes.

Mutations Associated With Disseminated Intravascular Coagulation in Acute Leukemia

Patient lays fatigued in hospital bed

No Change in Transplant Outcomes for DLBCL With Addition of Rituximab to Conditioning

As oncologists welcome new chronic lymphocytic leukemia treatments, one researcher creates a scoring system to make the case for transplants.

Richter Transformation Survival in CLL Appears Better Among Treatment-Naive

Complement C1s inhibition may prevent hemolysis in cold agglutinin disease.

Thromboembolism Incidence With Splenectomy for Automimmune Hemolytic Anemia

UPCOMING MEETINGS

December 7 – 10, 2019
American Society of Hematology Annual Meeting and Exposition
Orlando, FL

Click here to view the full calendar

DRUG NEWS FROM MPR

Priority Review Granted to Tazemetostat for Follicular Lymphoma Indication

Esperoct Now Available for Treatment of Hemophilia A

Bomedemstat Receives Fast Track Status for Essential Thrombocythemia

Avatrombopag Designated Orphan Drug for Chemo-Induced Thrombocytopenia

Adakveo Approved for Sickle Cell Disease

FDA Grants Accelerated Approval to Brukinsa for Mantle Cell Lymphoma

Reblozyl Approved for Anemia in Beta Thalassemia

Gene Therapy Gets Orphan Drug Status for Gaucher Disease

Ultomiris Receives Approval for Atypical Hemolytic Uremic Syndrome

FDA Approves Earlier Use of Nplate in Immune Thrombocytopenia

Next post in News

A scientist examines a blood sample.

ASCT May Offer Alternative for Tx of High-Risk Follicular Lymphoma